Price: R649,00 Mazdutide Dosage: 10mg Mazdutide is a dual GLP-1 and glucagon receptor agonist peptide currently being Price: R1399,00 Melanotan 2 Dosage: 10mg Melanocortin peptide studied for skin pigmentation and melanocortin receptor activity Price: R600,00 MOTS-c 10mg Dosage: 10mg Mitochondrial-derived peptide studied for metabolic regulation and fat cell activity Price: R639,00 MOTS-c 20mg Dosage: 20mg Mitochondrial-derived peptide studied for metabolic regulation and fat cell activity Price: R899,00 MOTS-c 40mg Dosage: 40mg Mitochondrial-derived peptide studied for metabolic regulation and fat cell activity Price: R1199,00 NAD+ 1000mg Dosage: 1000mg Nicotinamide adenine dinucleotide studied for cellular energy production and healthy ageing Price: R1099,00 NAD+ 500mg Dosage: 500mg Nicotinamide adenine dinucleotide studied for cellular energy production and healthy ageing Price: R699,00 Pinealon Dosage: 10mg Pinealon is a synthetic tripeptide bioregulator widely researched for its potential role in Price: R649,00 PT-141 Dosage: 10mg Melanocortin peptide studied for sexual function and arousal pathway regulation Price: R579,00 Pure Pen Cartridge Price: R75,00 Retatrutide 10mg Dosage: 10mg Triple receptor agonist studied for metabolic regulation and body weight management Price: R899,00 Retatrutide 20mg Dosage: 20mg Triple receptor agonist studied for metabolic regulation and body weight management Price: R1299,00 Retatrutide 30mg Dosage: 30mg Triple receptor agonist studied for metabolic regulation and body weight management Price: R1599,00 Retatrutide 40mg Dosage: 40mg Triple receptor agonist studied for metabolic regulation and body weight management Price: R1999,00 Selank Dosage: 10mg Heptapeptide studied for anxiety reduction and cognitive function in research settings Price: R720,00 Semaglutide 10mg Dosage: 10mg Semaglutide is a long-acting GLP-1 receptor agonist researched for chronic weight management, View Details Out of Stock Semaglutide 30mg Dosage: 30mg Semaglutide is a long-acting GLP-1 receptor agonist researched for chronic weight management, Price: R999,00 Semax Dosage: 10mg ACTH analogue studied for cognitive function, BDNF levels, and neuroprotection Price: R720,00 Sermorelin Dosage: 10mg Sermorelin is a synthetic growth hormone-releasing hormone (GHRH 129) analogue investigated for Price: R899,00 SLU-PP-332 Dosage: 5mg SLU-PP-332 is a synthetic pan-estrogen-related receptor (ERR//) agonist investigated in preclinical research Price: R599,00 SNAP-8 Dosage: 10 MG SNAP-8 (Acetyl Octapeptide-3) is an advanced cosmetic research peptide widely studied for Price: R499,00 SS-31 10mg Dosage: 10mg SS-31 (Elamipretide) is a mitochondria-targeted research peptide widely studied for its potential Price: R899,00 SS-31 50mg Dosage: 50mg SS-31 (Elamipretide) is a mitochondria-targeted research peptide widely studied for its potential Price: R1699,00 TB-500 10mg Dosage: 10mg Thymosin 4 fragment studied for tissue repair, wound healing, and recovery Price: R899,00 TB-500 5mg Dosage: 5mg Thymosin 4 fragment studied for tissue repair, wound healing, and recovery Price: R599,00 Tesamorelin 10mg Dosage: 10mg GHRH analogue studied for visceral fat reduction and metabolic regulation in Price: R1000,00 Tesamorelin 20mg Dosage: 20mg GHRH analogue studied for visceral fat reduction and metabolic regulation in Price: R1599,00 Tesamorelin 5mg Dosage: 5mg GHRH analogue studied for visceral fat reduction and metabolic regulation in Price: R750,00 Thymosin Alpha-1 Dosage: 10mg Thymic peptide studied for immune cell activation and T-lymphocyte regulation Price: R1149,00 Tirzepatide 15mg Dosage: 15mg Dual receptor agonist studied for blood sugar regulation and body weight Price: R799,00 Tirzepatide 30mg Dosage: 30mg Dual receptor agonist studied for blood sugar regulation and body weight Price: R1150,00 Tirzepatide 60mg Dosage: 60mg Dual receptor agonist studied for blood sugar regulation and body weight Price: R1699,00 VIP Dosage: 10mg Vasoactive intestinal peptide studied for anti-inflammatory activity and immune regulation Price: R1399,00 No peptides found
Clinical Stroke Trials Human clinical trials have yielded inconsistent results regarding efficacy: CARS trial (n=208): Demonstrated beneficial effects on global function and motor recovery in early rehabilitation patients[9] CASTA trial (n=1,070): Failed to show benefit over placebo in primary composite outcomes in Asian stroke patients[10] Meta-analyses suggest possible benefits in patients with severe stroke, but limited effects in mild-to-moderate cases[11] Safety profile comparable to placebo in most studies Neurodegenerative Disease Research Alzheimers Disease Models Research in transgenic mouse models of Alzheimers disease demonstrated effects on amyloid pathology and cognitive function[12]: Reduced amyloid plaque burden in APP transgenic mice Improved behavioral performance in memory tasks Decreased amyloid precursor protein maturation Effects maintained for 3 months after treatment discontinuation Vascular Dementia Studies Clinical investigations in vascular dementia patients showed more consistent positive findings[13]: Improved ADAS-cog cognitive scores (10.6-point improvement vs 4.4 points placebo) Enhanced global clinical function ratings (CIBIC+ scores) Benefits observed in 24-week treatment protocols with intravenous administration Effects demonstrated in multiple randomized controlled trials Traumatic Brain Injury Research Experimental TBI Models Studies in rat models of mild-to-moderate traumatic brain injury revealed dose-dependent functional improvements[14]: Enhanced long-term cognitive recovery at doses of 0.8-7.5 ml/kg Optimal dose identified as 2.5 ml/kg in closed head injury models Reduced astrogliosis and axonal injury markers Improved neurogenesis in dentate gyrus region Excitotoxicity Protection Research using kainic acid lesion models demonstrated neuroprotective effects[15]: Significant protection when administered before excitotoxic challenge Limited benefit when given after injury (therapeutic window considerations) Enhanced neuronal structure preservation in hippocampus Improved water maze performance in protected animals Critical Research Limitation: Clinical trial results for Cerebrolysin have been notably inconsistent
If you have any further questions or concerns, consult with your healthcare provider
That makes it the most cost-effective vial size for most researchers
Parkinsonism Relat Disord 17 , 117118 (2011)
